Literature DB >> 18619664

Advantages and disadvantages of accelerated immunotherapy schedules.

Linda Cox.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18619664     DOI： 10.1016/j.jaci.2008.06.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

2.  Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors.

Authors:  Ji Ho Lee; Su Chin Kim; Hyunna Choi; Chang Gyu Jung; Ga Young Ban; Yoo Seob Shin; Dong Ho Nahm; Hae Sim Park; Young Min Ye
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

3.  Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma.

Authors:  Giovanni Traina; Alberto Martelli; Salvatore Barberi; Amelia Licari; Gian Luigi Marseglia; Maria Angela Tosca; Giorgio Ciprandi
Journal:  Acta Biomed       Date:  2021-02-04

4.  Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children.

Authors:  Tipyapa Rattanamanee; Putthapoom Lumjiaktase; Nanthisa Kemawichanura; Potjanee Kiewnga; Wanlapa Jotikasthira; Wiparat Manuyakorn
Journal:  Asia Pac Allergy       Date:  2022-01-17

5.  How safe are the biologicals in treating asthma and rhinitis?

Authors:  Linda S Cox
Journal:  Allergy Asthma Clin Immunol       Date:  2009-10-22       Impact factor: 3.406

6.  Rush immunotherapy in two cats with atopic skin syndrome.

Authors:  Selene Jones; Paul Bloom
Journal:  JFMS Open Rep       Date:  2021-06-21

7.  An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.

Authors:  A M Chaker; B Al-Kadah; U Luther; U Neumann; M Wagenmann
Journal:  Clin Transl Allergy       Date:  2016-02-02       Impact factor: 5.871
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.